Your browser doesn't support javascript.
loading
AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States.
Melson, Joshua E; Imperiale, Thomas F; Itzkowitz, Steven H; Llor, Xavier; Kochman, Michael L; Grady, William M; Schoen, Robert E; Burke, Carol A; Shaukat, Aasma; Rabeneck, Linda; Ladabaum, Uri; Bresalier, Robert; Spiegel, Brennan; Yee, Judy; Wang, Thomas; Lieberman, David; Komanduri, Srinadh; Muthusamy, V Raman; Dey, Neelendu.
Afiliación
  • Melson JE; Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush Medical College, Chicago, Illinois. Electronic address: joshua_melson@rush.edu.
  • Imperiale TF; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Itzkowitz SH; The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Llor X; Department of Medicine and Cancer Center, Yale University, New Haven, Connecticut.
  • Kochman ML; Gastroenterology Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Grady WM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington.
  • Schoen RE; Department of Medicine and Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Burke CA; Division of Gastroenterology, Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.
  • Shaukat A; Department of Gastroenterology, University of Minnesota, Minneapolis, Minnesota.
  • Rabeneck L; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Ladabaum U; Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, California.
  • Bresalier R; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Spiegel B; Division of Gastroenterology, Department of Internal Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.
  • Yee J; Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York.
  • Wang T; Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Lieberman D; Division of Gastroenterology and Hepatology, School of Medicine, Oregon Health and Science University, Portland, Oregon.
  • Komanduri S; Division of Gastroenterology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Muthusamy VR; Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Dey N; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington.
Clin Gastroenterol Hepatol ; 18(12): 2667-2678.e2, 2020 11.
Article en En | MEDLINE | ID: mdl-32634626
The American Gastroenterological Association's Center for Gastrointestinal Innovation and Technology convened a consensus conference in December 2018, entitled, "Colorectal Cancer Screening and Surveillance: Role of Emerging Technology and Innovation to Improve Outcomes." The goal of the conference, which attracted more than 60 experts in screening and related disciplines, including the authors, was to envision a future in which colorectal cancer (CRC) screening and surveillance are optimized, and to identify barriers to achieving that future. This White Paper originates from that meeting and delineates the priorities and steps needed to improve CRC outcomes, with the goal of minimizing CRC morbidity and mortality. A one-size-fits-all approach to CRC screening has not and is unlikely to result in increased screening uptake or desired outcomes owing to barriers stemming from behavioral, cultural, and socioeconomic causes, especially when combined with inefficiencies in deployment of screening technologies. Overcoming these barriers will require the following: efficient utilization of multiple screening modalities to achieve increased uptake; continued development of noninvasive screening tests, with iterative reassessments of how best to integrate new technologies; and improved personal risk assessment to better risk-stratify patients for appropriate screening testing paradigms.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article